| 17beta-estradiol | multiple interactions | EXP | | 6480464 | AR protein affects the reaction [Estradiol results in increased expression of NKX3-1 mRNA]; more ... | CTD | PMID:17131305 |
| 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of NKX3-1 mRNA | CTD | PMID:17131305 |
| 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one | multiple interactions | EXP | | 6480464 | Dapsone analog inhibits the reaction [Metribolone results in increased expression of NKX3-1 mRNA] | CTD | PMID:21440447 |
| 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one | increases expression | EXP | | 6480464 | Metribolone results in increased expression of NKX3-1 mRNA | CTD | PMID:11751618 more ... |
| 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one | increases expression | EXP | | 6480464 | Metribolone results in increased expression of NKX3-1 mRNA | CTD | PMID:11751618 more ... |
| 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one | multiple interactions | EXP | | 6480464 | bicalutamide inhibits the reaction [Metribolone results in increased expression of NKX3-1 mRNA] | CTD | PMID:11751618 |
| 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one | increases expression | EXP | | 6480464 | Metribolone results in increased expression of NKX3-1 mRNA | CTD | PMID:17202838 more ... |
| 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one | increases expression | EXP | | 6480464 | Metribolone results in increased expression of NKX3-1 mRNA | CTD | PMID:17010675 more ... |
| 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one | increases expression | EXP | | 6480464 | Metribolone results in increased expression of NKX3-1 mRNA | CTD | PMID:21440447 more ... |
| 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one | increases expression | EXP | | 6480464 | Metribolone results in increased expression of NKX3-1 mRNA | CTD | PMID:21440447 more ... |
| 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one | multiple interactions | EXP | | 6480464 | TP53 protein inhibits the reaction [Metribolone results in increased expression of NKX3-1 mRNA] | CTD | PMID:17202838 |
| 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one | increases expression | EXP | | 6480464 | Metribolone results in increased expression of NKX3-1 protein | CTD | PMID:17303007 |
| 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one | increases expression | EXP | | 6480464 | Metribolone results in increased expression of NKX3-1 mRNA | CTD | PMID:17010675 more ... |
| 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one | decreases expression | EXP | | 6480464 | Metribolone results in decreased expression of NKX3-1 mRNA | CTD | PMID:12711008 |
| 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one | multiple interactions | EXP | | 6480464 | Metribolone promotes the reaction [AR protein binds to NKX3-1 promoter]; more ... | CTD | PMID:19318562 |
| 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one | multiple interactions | EXP | | 6480464 | Metribolone promotes the reaction [AR protein binds to NKX3-1 enhancer]; more ... | CTD | PMID:16603237 |
| 17beta-hydroxy-5alpha-androstan-3-one | decreases expression | EXP | | 6480464 | Dihydrotestosterone results in decreased expression of NKX3-1 mRNA | CTD | PMID:12711008 |
| 17beta-hydroxy-5alpha-androstan-3-one | multiple interactions | EXP | | 6480464 | PD 98059 inhibits the reaction [Dihydrotestosterone results in increased expression of NKX3-1 mRNA] | CTD | PMID:17131305 |
| 17beta-hydroxy-5alpha-androstan-3-one | increases expression | EXP | | 6480464 | Dihydrotestosterone results in increased expression of NKX3-1 mRNA | CTD | PMID:17131305 |
| 5-aza-2'-deoxycytidine | increases expression | EXP | | 6480464 | decitabine results in increased expression of NKX3-1 mRNA | CTD | PMID:18174752 |
| 9-cis-retinoic acid | increases expression | EXP | | 6480464 | alitretinoin results in increased expression of NKX3-1 mRNA; more ... | CTD | PMID:16763719 |
| aflatoxin B1 | increases expression | EXP | | 6480464 | Aflatoxin B1 results in increased expression of NKX3-1 mRNA | CTD | PMID:22100608 |
| all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of NKX3-1 protein; more ... | CTD | PMID:16817226 |
| bicalutamide | decreases expression | EXP | | 6480464 | bicalutamide results in decreased expression of NKX3-1 mRNA | CTD | PMID:15638997 |
| bicalutamide | multiple interactions | EXP | | 6480464 | bicalutamide inhibits the reaction [Metribolone results in increased expression of NKX3-1 mRNA] | CTD | PMID:11751618 |
| C60 fullerene | decreases expression | ISO | RGD:1305369 | 6480464 | fullerene C60 results in decreased expression of NKX3-1 mRNA | CTD | PMID:19167457 |
| celastrol | decreases expression | EXP | | 6480464 | tripterine results in decreased expression of NKX3-1 mRNA | CTD | PMID:17010675 |
| cisplatin | increases expression | EXP | | 6480464 | Cisplatin results in increased expression of NKX3-1 mRNA | CTD | PMID:19561079 |
| clofibrate | increases expression | ISO | RGD:1313355 | 6480464 | Clofibrate results in increased expression of NKX3-1 mRNA | CTD | PMID:17585979 |
| crocidolite asbestos | increases expression | EXP | | 6480464 | Asbestos, Crocidolite results in increased expression of NKX3-1 mRNA | CTD | PMID:18687144 |
| curcumin | decreases expression | EXP | | 6480464 | Curcumin results in decreased expression of NKX3-1 mRNA; more ... | CTD | PMID:17303007 PMID:18719366 |
| curcumin | decreases expression | EXP | | 6480464 | Curcumin results in decreased expression of NKX3-1 protein; more ... | CTD | PMID:18719366 PMID:17303007 |
| daidzein | decreases expression | EXP | | 6480464 | daidzein results in decreased expression of NKX3-1 mRNA | CTD | PMID:16865672 |
| dapsone | multiple interactions | EXP | | 6480464 | Dapsone analog inhibits the reaction [Metribolone results in increased expression of NKX3-1 mRNA] | CTD | PMID:21440447 |
| flufenamic acid | multiple interactions | EXP | | 6480464 | Flufenamic Acid inhibits the reaction [mibolerone results in increased expression of NKX3-1 mRNA] | CTD | PMID:10537180 |
| flutamide | multiple interactions | EXP | | 6480464 | [Flutamide binds to and results in decreased activity of AR protein] which results in decreased expression of NKX3-1 protein | CTD | PMID:17303007 |
| flutamide | decreases expression | EXP | | 6480464 | Flutamide results in decreased expression of NKX3-1 protein | CTD | PMID:17303007 |
| fulvestrant | multiple interactions | EXP | | 6480464 | fulvestrant inhibits the reaction [Estradiol results in increased expression of NKX3-1 mRNA] | CTD | PMID:17131305 |
| fulvestrant | multiple interactions | ISO | RGD:1313355 | 6480464 | fulvestrant inhibits the reaction [Genistein results in decreased expression of NKX3-1 mRNA] | CTD | PMID:21810550 |
| gedunin | decreases expression | EXP | | 6480464 | gedunin results in decreased expression of NKX3-1 mRNA | CTD | PMID:17010675 |
| genistein | decreases expression | EXP | | 6480464 | Genistein results in decreased expression of NKX3-1 mRNA | CTD | PMID:16865672 PMID:15378649 |
| genistein | increases expression | ISO | RGD:1313355 | 6480464 | Genistein results in increased expression of NKX3-1 mRNA | CTD | PMID:21810550 |
| genistein | multiple interactions | ISO | RGD:1313355 | 6480464 | fulvestrant inhibits the reaction [Genistein results in decreased expression of NKX3-1 mRNA] | CTD | PMID:21810550 |
| genistein | decreases expression | EXP | | 6480464 | Genistein results in decreased expression of NKX3-1 mRNA | CTD | PMID:15378649 PMID:16865672 |
| indomethacin | increases expression | EXP | | 6480464 | Indomethacin results in increased expression of NKX3-1 mRNA | CTD | PMID:16984733 |
| paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of NKX3-1 mRNA | CTD | PMID:21420995 |
| piroxicam | multiple interactions | EXP | | 6480464 | Piroxicam inhibits the reaction [mibolerone results in increased expression of NKX3-1 mRNA] | CTD | PMID:10537180 |
| quercetin | decreases expression | EXP | | 6480464 | Quercetin results in decreased expression of NKX3-1 mRNA | CTD | PMID:11238180 |
| resveratrol | decreases expression | EXP | | 6480464 | resveratrol results in decreased expression of NKX3-1 mRNA | CTD | PMID:18586690 |
| tert-butyl hydroperoxide | increases expression | EXP | | 6480464 | tert-Butylhydroperoxide results in increased expression of NKX3-1 mRNA | CTD | PMID:15336504 |
| tetramethrin | decreases expression | EXP | | 6480464 | tetramethrin results in decreased expression of NKX3-1 mRNA | CTD | PMID:12711008 |
| trans-resveratrol | decreases expression | EXP | | 6480464 | resveratrol results in decreased expression of NKX3-1 mRNA | CTD | PMID:18586690 |
| valproic acid | increases expression | ISO | RGD:1313355 | 6480464 | Valproic Acid results in increased expression of NKX3-1 mRNA | CTD | PMID:21427059 |
| zinc atom | multiple interactions | EXP | | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of NKX3-1 mRNA | CTD | PMID:18593933 |
| zinc(0) | multiple interactions | EXP | | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of NKX3-1 mRNA | CTD | PMID:18593933 |